课题基金 / 基金详情

项目摘要

项目成果

DAVID W CHRISTIANSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Our laboratory focuses on the development of ruthenium complexes as kinetically inert enzyme inhibitors. In this concept, the metal center controls the orientation of the organic ligands to achieve unique three-dimensional structures that match the enzyme active site. X-ray crystallography of target enzymes with bound organoruthenium compounds are a central part of this effort. We recently developed nanomolar and even picomolar inhibitors for the glycogen synthase kinase-3beta (GSK-3beta). Co-crystal structural analyses of some organoruthenium complexes bound to Pim1 verify a binding in the ATP-binding site as designed (Angew. Chem. Int. Ed. 2006, 45, 1580). The protein kinases GSK-3 and Pim1 have been found to be related to prostate cancers, colorectal cancers, and melanoma, and their modulation is therefore of high interest. We are now especially interested in improving the affinity and selectivity of our lead structures for GSK-3. The functilnal groups in the active side that that are responsible for the potency and selectivity of the metal complexes will be investigated by introducing mutations in the active site of GSK-3. This work will include the following aim: Obtaining co-crystal structures of native and mutant GSK-3beta with the organoruthenium inhibitors: These structures will allow us to understand the binding mode in detail and to design second generation inhibitors for GSK-3. We already obtained cocrystals with one of the first generation compounds. These crystals did not diffract at the in-house X-Ray source (R axis IV++ image plate detector mounted on a Rigaku-200HB rotating anode X-ray generator, Christianson Lab). However, we were able to collect a complete data set at CHESS F1beamline (in collaboration with Dr. David Christiansons Lab). These crystals diffracted up to 3.1 ¿ and the unit cell parameters were determined. The purpose of this proposal is to request beam time to collect high-resolution data sets that will be obtained from crystals with better quality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure-Based Design of Xe-129 NMR Biosensors for Multiplexed Cancer Detection
  • 批准号:
    8901574
  • 项目类别:
  • 资助金额:
    $5.59万
  • 财政年份:
    2011
  • 负责人:
    DAVID W CHRISTIANSON
  • 依托单位:
X-RAY CRYSTALLOGRAPHIC STUDIES OF METAL-REQUIRING ENZYMES
  • 批准号:
    8361623
  • 项目类别:
  • 资助金额:
    $1.65万
  • 财政年份:
    2011
  • 负责人:
    DAVID W CHRISTIANSON
  • 依托单位:
Structure-Based Design of Xe-129 NMR Biosensors for Multiplexed Cancer Detection
  • 批准号:
    8658105
  • 项目类别:
  • 资助金额:
    $39.79万
  • 财政年份:
    2011
  • 负责人:
    DAVID W CHRISTIANSON
  • 依托单位:
Structure-Based Design of Xe-129 NMR Biosensors for Multiplexed Cancer Detection
  • 批准号:
    8185940
  • 项目类别:
  • 资助金额:
    $37.4万
  • 财政年份:
    2011
  • 负责人:
    DAVID W CHRISTIANSON
  • 依托单位:
海外基金